The stock is trading -94.24 percent below its 52-week high and 77.17 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a ...
ROTH Capital raised the price target for the Monopar Therapeutics Inc (NASDAQ:MNPR) stock to “a Buy”. The rating was released on January 28, 2021, according to finviz.
Some results have been hidden because they may be inaccessible to you